Gilead Sciences To Rally Around 28%? Here Are 10 Other Analyst Forecasts For Tuesday

  • Morgan Stanley raised the price target for DraftKings Inc. DKNG from $23 to $25. Morgan Stanley analyst Stephen Grambling maintained an Overweight rating. DraftKings shares fell 0.2% to close at $23.49 on Monday.
  • Keefe, Bruyette & Woods boosted the price target for Selective Insurance Group, Inc. SIGI from $104 to $106. Keefe, Bruyette & Woods analyst Meyer Shields maintained a Market Perform rating. Selective Insurance shares gained 0.3% to close at $103.02 on Monday.
  • TD Securities cut the price target for Absolute Software Corporation ABST from $16 to $11.5. TD Securities analyst David Kwan downgraded the stock from Buy to Tender. Absolute Software shares fell 0.3% to $11.30 in pre-market trading.
  • Goldman Sachs raised XP Inc. XP price target from $20 to $22. Goldman Sachs analyst Tito Labarta maintained a Buy rating. XP shares fell 0.3% to $15.71 in pre-market trading.
  • UBS cut Lincoln National Corporation LNC price target from $37 to $21. UBS analyst Brian Meredith maintained a Neutral rating. Lincoln National shares rose 2.1% to $19.99 in pre-market trading.
  • Mizuho raised the price target for Toast, Inc. TOST from $23 to $25. Mizuho analyst Dan Dolev maintained a Buy rating. Toast shares rose 0.8% to $19.59 in pre-market trading.
  • Truist Securities cut Warner Music Group Corp. WMG price target from $37 to $32. Truist Securities analyst Matthew Thornton maintained a Buy rating. Warner Music shares rose 4.2% to close at $26.34 on Monday.
  • Cantor Fitzgerald slashed Clene Inc. CLNN price target from $5 to $4. Cantor Fitzgerald analyst Charles Duncan maintained a Buy rating. Clene shares rose 3.8% to $0.9150 in pre-market trading.
  • Stifel cut The Mosaic Company MOS price target from $46 to $42.. Stifel analyst Vincent Anderson maintained a Hold rating. Mosaic shares fell 0.1% to $36.58 in pre-market trading.
  • Mizuho boosted HCA Healthcare, Inc HCA price target from $298 to $305. Mizuho analyst Ann Hynes maintained a Buy rating. HCA Healthcare shares fell 0.6% to $276.00 in pre-market trading.
  • BMO Capital increased Gilead Sciences, Inc. GILD price target from $90 to $100. BMO Capital analyst Evan Seigerman upgraded the stock from Market Perform to Outperform. Gilead Sciences shares rose 0.3% to close at $78.38 on Monday.

Check This Out: $1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalyst forecastsFinancialsLife & Health InsurancePT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!